The California Institute for Regenerative Medicine (CIRM), the state's stem cell agency, has awarded a two-year, $6 million ...

The California Institute for Regenerative Medicine has funded Keck School of Medicine of USC translational research advancing ...

New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

Dry AMD is one of the two forms of the ocular disease that ranks as the leading cause of blindness in adults over age 65, driven by the slow loss of photoreceptor cells over time. Dry AMD begins ...

4). AMD progressively damages the center of the retina, the light-detecting region at the back of the eye. Recent data ...

Most folks with macular degeneration will have the dry type for their whole life. This form of AMD affects your vision slowly over time. But around 10%-15% of people with dry AMD will get wet AMD ...

The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to treat dry age-related macular degeneration (AMD). Valeda is said to ...

We will assess its ability to slow down disease progression and help preserve vision for Stargardt disease and dry AMD patients." Christopher Cioffi, Rensselaer Polytechnic Institute AMD is the ...